INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

VORVor Biopharma Inc.

CIK 0001817229

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score9
Connections4with evidence

VOR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
JW
Joustra WouterDirector
VORVor Biopharma Inc.
Grant or award
A—
3,000 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 5, 2026
  • ← Insider ofevidence
    Joustra WouterDirector · Dec 19, 2025
  • ← Insider ofevidence
    Levin Andrew DavidDirector · Dec 19, 2025
  • ← Insider ofevidence
    Zuraw Qing CheChief Development Officer · Dec 9, 2025
9
LD
Levin Andrew DavidDirector
VORVor Biopharma Inc.
Grant or award
A
—
3,000 sh
Dec 18, 2025
Dec 19, 2025
traded Dec 18, 2025
+1d
SEC FORM 4

Evidence

9
ZC
Zuraw Qing CheChief Development Officer
VORVor Biopharma Inc.
Disposition to issuer
D—
218.7K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

9
ZC
Zuraw Qing CheChief Development Officer
VORVor Biopharma Inc.
Grant or award
A—
218.7K sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence